BTS member Jungkook's brand logo has been registered in eight countries, including the United States, Europe, and Japan, ...

Northstrive Biosciences announced an update for its obesity treatment candidates, EL-22 and EL-32, both aimed at optimizing fat loss while ...

As of Jan. 29, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.

SEOUL, South Korea — North Korean leader Kim Jong Un inspected a facility that produces nuclear material and called for bolstering the country’s nuclear fighting capability, state media ...

Kerry, a global business in taste and nutrition, has outlined five distinct consumer segments among those who consume GLP-1s, each with unique preferences and needs, providing a framework for future ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

SEOUL, South Korea — Few people understand what may be going through the minds of North Korean soldiers fighting and dying for Russia in the war against Ukraine. But Lee Chul Eun is one of them.

Copyright 2025 The Associated Press. All Rights Reserved. A TV screen at Seoul Railway Station in South Korea, on Oct. 21, 2024, shows an image of soldiers believed ...

Bariatric procedures fell modestly for the full year 2024, given the rise in GLP-1 medications ... a result of healthy growth in Korea, Japan, and Europe and solid growth in the U.S. On the ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle mass and overall body composition.